Asklepion Pharmaceuticals, LLC
L-citrulline
Sickle Cell Disease
Countdown
358days
Phase 3 readout · ~ Jun 30, 2027 estimated
What's at stake
Phase 3 trial results for L-citrulline in Sickle Cell Disease are due ~ Jun 30, 2027. A clean hit validates the program; a miss can gap the stock down hard.
Primary source
· ClinicalTrials.gov
verified 15h ago
“CT.gov NCT06989567: Phase 3 trial, sponsor Asklepion Pharmaceuticals, LLC, drug L-citrulline. Primary completion date 2027-06 (estimated).”